Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,402,160
-$23,214,890 QoQ
Shares Held
90,722
-50.2% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#98
of 1,044 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $550,105,949 across 22 Diagnostics & Research names. LH ranks #9 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
433,146 | $98,233,181 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
139,499 | $69,939,218 | |
| 3 | ILMN |
Illumina, Inc.
|
356,183 | $62,627,656 | |
| 4 | DHR |
Danaher Corp /De/
|
235,913 | $44,936,708 | |
| 5 | SHC |
Sotera Health Co
|
2,206,457 | $39,164,611 | |
| 6 | A |
Agilent Technologies, Inc.
|
256,435 | $34,062,261 | |
| 7 | NTRA |
Natera, Inc.
|
102,398 | $27,795,937 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
140,692 | $27,184,508 |
All Filings in LH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,402,160 | 90,722 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $48,617,050 | 182,216 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $40,562,529 | 161,681 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $27,279,024 | 95,029 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,923,657 | 68,278 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $14,619,795 | 62,816 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,880,452 | 25,643 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||